PT Medela Potentia Tbk (ISX:MDLA) Other Financing: Rp500,682 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:MDLA PT Medela Potentia Tbk ISX:MDLA
13 GF Score
Price Rp208.00
! 1 Warning Sign
View Full Analysis

What is PT Medela Potentia Tbk Other Financing?

PT Medela Potentia Tbk ISX:MDLA +0.97% 13 Other Financing is Rp500,682 Mil as of Mar. 2026. GuruFocus rates ISX:MDLA with a GF Score™ of 13/100. The stock has 1 warning sign investors should review.

PT Medela Potentia Tbk's Other Financing for the three months ended in Mar. 2026 was Rp0 Mil.

PT Medela Potentia Tbk's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was Rp500,682 Mil.

PT Medela Potentia Tbk Other Financing Historical Data

* Premium members only.

The historical data trend for PT Medela Potentia Tbk's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Medela Potentia Tbk Other Financing Chart

PT Medela Potentia Tbk Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
-16.00 39,133.00 -1,162.00 8,272.00 -19,992.00

PT Medela Potentia Tbk Quarterly Data
Dec21 Dec22 Dec23 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 639,278.00 -140,127.00 1,531.00 0.00
ISX:MDLA
13GF Score
PT Medela Potentia Tbk ISX:MDLA
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Medela Potentia Tbk Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp500,682 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of Rp500,682 Mil mean?
PT Medela Potentia Tbk (ISX:MDLA) has a Other Financing of Rp500,682 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for PT Medela Potentia Tbk and its competitors.
Is PT Medela Potentia Tbk's Other Financing too high?
PT Medela Potentia Tbk's current Other Financing is Rp500,682 Mil. Overall, PT Medela Potentia Tbk has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does PT Medela Potentia Tbk's Other Financing compare to MCK and CAH?
PT Medela Potentia Tbk's Other Financing of Rp500,682 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Medical Distribution company?
A good Other Financing depends on the Medical Distribution industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for PT Medela Potentia Tbk and its competitors. PT Medela Potentia Tbk's current Other Financing is Rp500,682 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Medela Potentia Tbk stock overvalued right now?
PT Medela Potentia Tbk (ISX:MDLA) has a current Other Financing of Rp500,682 Mil. The current Other Financing is Rp500,682 Mil. PT Medela Potentia Tbk's overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For PT Medela Potentia Tbk (ISX:MDLA), the current Other Financing is Rp500,682 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Medela Potentia Tbk Business Description

Address Jl. RS Fatmawati Kav. 33, Cilandak Barat, Jakarta Selatan, Jakarta, IDN, 12430
PT Medela Potentia Tbk is a healthcare-focused holding company engaged in pharmaceutical distribution, medical device manufacturing, and marketing services. It is engaged in the distribution and marketing of pharmaceutical products, health products, and medical devices. It also manufactures medical devices and implements web portals and digital platforms for commercial purposes through its subsidiaries. The Company manages three main operating segments, namely pharmaceutical products, healthcare products, and medical devices.
13GF Score

Get the complete analysis for ISX:MDLA

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp208.00
Price